MarketPulse
C

$CODX

2 articles found
1 positive
1 negative
0 neutral
BenzingaBenzinga··Prnewswire

Co-Diagnostics Reports Sharp Revenue Decline, $46.9M Loss as Cash Reserves Dwindle

Co-Diagnostics ($CODX) posted $0.6M revenue and $46.9M net loss in 2025, down from prior year, amid strategic joint ventures and pipeline advancement.
CODXfinancial resultscommercialization
BenzingaBenzinga··Prnewswire

Co-Diagnostics Advances TB Testing in India Following WHO Guidance on Molecular Diagnostics

Co-Diagnostics ships PCR instruments and TB test kits to India for clinical studies, aligned with new WHO recommendations for molecular testing using tongue swabs.
CODXregulatory approvalIndia expansion